COVID-19 Frontliners: Searching for the Silver Bullet
Clinical trial leader Annie Luetkemeyer, MD, tests promising therapies for COVID-19 – and soon a vaccine.
University of California San Francisco
Give to UCSFClinical trial leader Annie Luetkemeyer, MD, tests promising therapies for COVID-19 – and soon a vaccine.
When future historians look back on this moment, they will draw many conclusions from our response to this crisis. Here are five big lessons that UCSF experts already see taking shape.
Call navigator Monique Posey fields questions about the pandemic. She shares her story – and some of her strategies for coping with stress.
As Emergency Medicine Chief, Maria Raven, MD, takes charge of the hospital’s first line of defense.
Custodian Abie Stillman shares his reflections on essential work and what he would like instead of another thank-you.
Between shifts at San Francisco’s public hospital, physician and podcast host Emily Silverman, MD, collects audio diaries from health workers across the nation.
Surgical charge nurse Alicia Catanese, RN, volunteered to help the Navajo Nation cope with its COVID surge.
When your child has a serious medical condition, social distancing is all too familiar. Five families have some advice for the rest of us.
Exceptional care was crucial, but I’m painfully aware that privilege also pulled me through.
Child life specialist Katie Craft helps young patients grapple with new fears.
Amid the COVID-19 chaos in many hospitals, emergency medicine physicians in seven cities around the country experienced rising levels of anxiety and emotional exhaustion, regardless of the intensity of the local surge, according to a new analysis led by UCSF.
Among a group of 40 health care professionals observed by the study authors, those without masks touched their faces nearly four times as often as those who wore masks, indicating that masks not only are an effective barrier to disease transmission, but also may reduce face-touching, at least among health care professionals.
The researchers determined "medical vulnerability" by referencing indicators identified by the CDC, including heart conditions, diabetes, current asthma, immune conditions (such as lupus, gout, rheumatoid arthritis), liver conditions, obesity and smoking within the previous 30 days. Additionally, the researchers added e-cigarettes to tobacco and cigar use.
As the COVID-19 spreads through America’s overcrowded jails and prisons, researchers with Amend at UCSF are cautioning against using punitive solitary confinement to medically isolate infected people.
Scientists have identified key chemical building blocks for an eventual antiviral drug against SARS-CoV-2, the virus that causes COVID-19.
In 2020, as the world faces another new virus stoking fear and uncertainty, San Francisco may be uniquely up to the challenge. Strong ties between UCSF, local government agencies and community groups, forged in the fire of the AIDS epidemic, and a deep bench of infectious disease expertise, has helped the city flatten the curve and better understand this new disease.
With the COVID-19 pandemic, travel this year will be different from years past.
The declaration of COVID-19 as a global pandemic in March resulted in a rapid decrease in step counts worldwide.
UCSF scientists assembled an international research team that has figured out how SARS-CoV-2, the virus that causes COVID-19, hijacks proteins in host cells that serve as master regulators of key cellular processes.
LGBTQ+ communities have experienced increased anxiety and depression since the onset of the COVID-19 pandemic, especially those who haven’t struggled with these conditions before.
The use of telehealth, sharing medical information and communicating electronically, has increased dramatically in the wake of the COVID-19 pandemic